Pharmaceutical Composition For Treatment Of 2 Type Dabetes

Patent No. EP2402342 (titled "Pharmaceutical Composition For Treatment Of 2 Type Dabetes") was filed by Jiangsu Hengrui Medicine on Mar 8, 2010. The application was issued on Aug 6, 2014.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
GENERICS UK TRADING MYLAN	May 6, 2015	JOHNSON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jul 1, 2016
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jul 1, 2016
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jun 28, 2016
Termination of the opposition proceedings with revocation of patent
Mar 2, 2016
Advice of delivery
Feb 29, 2016
Advice of delivery
Feb 29, 2016
Advice of delivery
Feb 23, 2016
Acknowledgement of a document
Feb 23, 2016
Acknowledgement of a document
Feb 23, 2016
Decision of the Opposition Division and instruction
Feb 23, 2016
Decision revoking the European patent
Feb 23, 2016
Grounds for the decision (Annex) - opposition
Feb 23, 2016
Internal form - Opposition/addressees
Jun 30, 2015
Brief communication - Opposition proceedings
Jun 30, 2015
Communication concerning statement of surrender/lapse of patent/failure to reply to a notice of opposition
Jun 22, 2015
Letter regarding the opposition procedure (no time limit)
Jun 19, 2015
Communication of a notice of opposition and request to file observations
Jun 19, 2015
Letter accompanying subsequently filed items
Jun 19, 2015
Letter regarding the opposition procedure (no time limit)
Jun 19, 2015
Notice of further oppositions to opponent(s)
May 19, 2015
Communication of a notice of opposition - first information to patent proprietor
May 6, 2015
(Electronic) Receipt
May 6, 2015
Any annexes (other than citation) to an opposition letter
May 6, 2015
Citation in opposition procedure
May 6, 2015
Non-patent literature cited during the opposition procedure
May 6, 2015
Notice of opposition
May 6, 2015
Notice of opposition
May 6, 2015
Patent document cited during the opposition procedure
May 6, 2015
Patent document cited during the opposition procedure
May 6, 2015
Patent document cited during the opposition procedure
May 6, 2015
Patent document cited during the opposition procedure
May 6, 2015
Patent document cited during the opposition procedure
May 6, 2015
Patent document cited during the opposition procedure
May 6, 2015
Patent document cited during the opposition procedure
May 6, 2015
Translation of the evidence during Opposition procedure
Aug 7, 2014
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 10, 2014
Decision to grant a European patent
Jun 16, 2014
Filing of the translations of the claims
Jun 16, 2014
French translation of claims
Jun 16, 2014
German translation of the claims
Jun 16, 2014
Payment of fees and costs
Feb 24, 2014
Bibliographic data of the European patent application
Feb 24, 2014
Communication about intention to grant a European patent
Feb 24, 2014
Intention to grant (signatures)
Feb 24, 2014
Text intended for grant
Sep 23, 2013
(Electronic) Receipt
Sep 23, 2013
Amended claims with annotations
Sep 23, 2013
Claims
Sep 23, 2013
Letter accompanying subsequently filed items
Sep 23, 2013
Reply to communication from the Examining Division
Jun 4, 2013
Annex to the communication
Jun 4, 2013
Communication from the Examining Division
Mar 5, 2013
Amended claims filed after receipt of (European) search report
Mar 5, 2013
Amended claims with annotations
Mar 5, 2013
Amendments received before examination
Mar 5, 2013
Non-patent literature cited during the examination procedure
Mar 4, 2013
Amended claims filed after receipt of (European) search report
Mar 4, 2013
Amended claims with annotations
Mar 4, 2013
Amendments received before examination
Mar 4, 2013
Non-patent literature cited during the examination procedure
Nov 2, 2012
Communication of amended entries concerning the representative
Oct 19, 2012
Submission concerning change of applicant's representative
Oct 12, 2012
Communication to designated inventor
Oct 12, 2012
Communication to designated inventor
Sep 24, 2012
Copy of the international preliminary report on patentability
Sep 24, 2012
Translation of the international preliminary report on patentability
Sep 6, 2012
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Aug 20, 2012
Communication regarding the transmission of the European search report
Aug 20, 2012
European search opinion
Aug 20, 2012
Supplementary European search report
Dec 7, 2011
Notification of forthcoming publication
Nov 3, 2011
Communication regarding possible amendment of the application/payment of claims fee
Nov 3, 2011
The request for correction will be decided by the Examining Division
Oct 4, 2011
Notification of withdrawal of priority claim
Sep 30, 2011
(Electronic) Receipt
Sep 30, 2011
Abstract
Sep 30, 2011
Amended claims filed after receipt of (European) search report
Sep 30, 2011
Annex
Sep 30, 2011
Claims
Sep 30, 2011
Description
Sep 30, 2011
Request for entry into the European phase
Aug 12, 2011
Information on entry into European phase
Oct 29, 2010
Priority document (electronically transmitted)
Oct 7, 2010
Copy of the international search report
Oct 7, 2010
Copy of the translated international search report
Oct 7, 2010
International publication pamphlet

EP2402342

JIANGSU HENGRUI MEDICINE

Application Number: EP10758007A
Filing Date: Mar 8, 2010
Status: Revoked
Publication Date: Aug 6, 2014
External Links: Slate, Register , Google Patents

IP Verse

Pharmaceutical Composition For Treatment Of 2 Type Dabetes

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2402342